Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

J. Compston, D. M. Reid, J. Boisdron, M. -L. Brandi, N. Burlet, D. Cahall, P. D. Delmas, W. Dere, J. -P. Devogelaer, L. A. Fitzpatrick, B. Flamion, N. Goel, S. Korte, A. Laslop, B. Mitlak, S. Ormarsdottir, J. Ringe, R. Rizzoli, Y. Tsouderos, T. Van StaaJ. -Y. Reginster

Research output: Contribution to journalArticle

22 Citations (Scopus)
Original languageEnglish
Pages (from-to)1247-1250
Number of pages4
JournalOsteoporosis International
Issue number9
Early online date5 Jul 2008
Publication statusPublished - Sept 2008


  • bone mineral density
  • bridging study
  • glucocorticoid-induced osteoporosis
  • men
  • phase III studies
  • postmenopausal women
  • corticosteroid-induced osteoperosis
  • oral corticosteroids
  • fracture risk
  • bone loss
  • metaanalysis
  • risedronate
  • alendronate
  • therapy

Cite this